CDSCO monthly lab alert
CDSCO NSQ alert, November 2025: 216 drug batches flagged
By Blacklisted editorial team· Published 20 Dec 2025· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its November 2025 alert, the Central Drugs Standard Control Organisation listed 216 drug batches that failed quality tests, 64 at central laboratories and 152 at state drug-testing laboratories, from 166 manufacturers across 142 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Calcium Phosphate & Vitamin D3 Suspension, Telmisartan Tablets IP 40 mg, Telmisartan & Amlodipine Tablets IP.
216
Batches flagged
64 / 152
Central / state labs
Assay
Top reason
166
Manufacturers
Batches per month, last 12 alerts
Dec 2024Nov 2025 · 216
Full list of NSQ batches, November 2025
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| �(Cyproheptadine Hydrochloride & Tricholine Citrate syrup) | Batch MDL-B641Mfg Nov 2024 · Exp Oct 2026 | Marvellon Pharmaceuticals Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Zedrest-Plus | Batch VDET-288Mfg Dec 2023 · Exp Nov 2025 | Vzoic Healthcare Pvt. LtdPunjab | Disintegration TestDisintegration | SDT&RL, BhubaneswarState lab |
| Voglibose Tablets IP 0.3mg | Batch LC25D111AMfg Apr 2025 · Exp Mar 2027 | Lifecare Neuro Products Ltd. 70/1Himachal Pradesh | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Trypsin-Chymortypsin Tablets | Batch 2KU6L012Mfg Feb 2024 · Exp Jan 2027 | Torrent Pharmaceuticals LtdSikkim | Enzymatic Activity (Trypsin & Chymotrypsin) and Disintegration (Acid stage)Disintegration | Food & Drugs Laboratory, VadodaraState lab |
| Tramadol & Paracetamol Tablets IP | Batch BT-1322Mfg Mar 2025 · Exp Feb 2027 | Badrivas Biotech Pvt. LtdUttarakhand | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Terbutaline Sulphate, Ambroxol Hydrochloride & Choline Theophylinate | Batch SR-10Mfg May 2025 · Exp Apr 2028 | Sresan Pharmaceutical ManufacturerKarnataka | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Telmisartan Tablets IP 80 mg | Batch TST 4510Mfg Aug 2025 · Exp Jul 2027 | Modern LaboratoriesMadhya Pradesh | The sample does not conform to standard quality in respect of the tests for "Description" performed.Description | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| Telmisartan Tablets IP 40 mg | Batch BPLT-24302Mfg Oct 2024 · Exp Sep 2026 | Bennet Pharmaceuticals LtdHimachal Pradesh | The sample does not conform to IP with respect to the reason stated under Description.Description | CDTL,IndoreCDSCO lab |
| Telmisartan Tablets IP 40 mg | Batch ED24290Mfg Sep 2024 · Exp Aug 2026 | Elfin Drugs Pvt. LtdHimachal Pradesh | The sample is declared to be Not of Standard Quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Telmisartan Tablets IP 40 mg | Batch ED25088Mfg Jul 2025 · Exp Jun 2027 | Elfin Drugs Pvt. LtdHimachal Pradesh | The sample is declared to be Not of Standard Quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Telmisartan & Hydrochlorothizide Tablets IP | Batch B25X021Mfg Dec 2024 · Exp Nov 2026 | Mankind Pharma LtdSikkim | test for Dissolution of Telmisartan onlyDissolution | RDTL, Hubli, KarnatakaState lab |
| Telmisartan & Amlodipine Tablets IP | Batch MLS-241413Mfg Jan 2025 · Exp Dec 2026 | Maskon Life Sciences Pvt. LtdUttarakhand | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Telmisartan & Amlodipine Tablets IP | Batch TGT296AMfg Jul 2024 · Exp Jun 2026 | Amster LabsHimachal Pradesh | Dissolution (For Telmisartan)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Tablets of Supator-20 (AtorvastatinTablets IP 20mg) | Batch SRTB240152Mfg Feb 2024 · Exp Jan 2026 | Systole Remedies Pvt. LtdHimachal Pradesh | Content of AtorvastatinOther | SDT&RL, BhubaneswarState lab |
| Tablets of Glimepiride Tablets I.P.2mg | Batch SGO-103Mfg Jan 2025 · Exp Dec 2026 | Marc LifesciencesSikkim | DescriptionDescription | SDT&RL, BhubaneswarState lab |
| Sucralfate and Oxetacaine Suspension | Batch L250813Mfg Aug 2025 · Exp Jul 2027 | SGS Formulation Pvt Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Sucralfate & Oxetacaine Suspension | Batch SCO-2503Mfg Jun 2025 · Exp May 2027 | Apple Formulations Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Sucralfate & Oxetacaine Oral Suspension | Batch JLD25C14AMfg Mar 2025 · Exp Feb 2027 | Jaiwik Biotech (P) LtdRajasthan | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Sterile Water For Injection I.P | Batch W25010Mfg Apr 2025 · Exp Mar 2028 | Vivek Pharmaceuticals Pvt. LtdJammu & Kashmir | BETOther | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Spoorthi Aloegramflour Soap | Batch 6Mfg Jun 2024 · Exp May 2027 | Spoorthi Herbals No.:299Karnataka | Test for Matter Insoluble in Alcohol onlyOther | RDTL, Hubli, KarnatakaState lab |
| Sorbitol Solution 70% IP | Batch KA/018Mfg Sep 2025 · Exp Aug 2030 | Gujarat Ambuja Exports LtdGujarat | Ethylene Glycol-0.144% (Limit-0.1%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Sorbitol 70% IP | Batch KA/018Mfg Sep 2025 · Exp Aug 2030 | Gujarat Ambuja Exports LtdGujarat | Ethylene Glycol-0.154% (Limit-0.1%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Sodium Valproate and Valproic Acid Controlled Release Tablets | Batch ST-240134Mfg Jan 2024 · Exp Dec 2025 | Supermax Drugs & Drugs Pharmaceuticals Pvt. Ltd. (Unit-II)Uttarakhand | DescriptionDescription | SDT&RL, BhubaneswarState lab |
| Sodium Valproate Tablets IP 300 mg | Batch RG24129TMfg Mar 2024 · Exp Feb 2026 | Rescures LIfe Sciences Ltd. 131-132 EPIP Phase-1Himachal Pradesh | The sample is not of standard quality for the reason stated under "Description" of the tablets.Description | RDTL, GuwahatiCDSCO lab |
| Sodium Valproate Gastro-resistant Tablets I.P. 200 mg. | Batch 425-263Mfg Jan 2025 · Exp Dec 2026 | Zee Laboratories Ltd. Behind 47Himachal Pradesh | The sample is not of standard quality for the reason stated under "Description" of the tablets.Description | RDTL, GuwahatiCDSCO lab |
| Sodium Valproate Gastro resistant Tablets IP 200 mg. | Batch 03637Mfg Mar 2024 · Exp Feb 2026 | Healthy Life Pharma Pvt. Ltd. Factory : N ? 31/1Maharashtra | The sample is not of standard quality for the reason stated under "Description" of the tablets.Description | RDTL, GuwahatiCDSCO lab |
| Sodium Valproate & Valproic Acid Controlled Release Tablets | Batch ADT25196BMfg Jan 2025 · Exp Dec 2026 | Astonea Labs Pvt. LtdHaryana | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Sodium ValproateAssay | RDTL,ChandigarhCDSCO lab |
| Simethicone Oral Suspension U.S.P | Batch 1503Mfg Mar 2025 · Exp Feb 2027 | Pulse Pharma MFG. CoGujarat | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Restol 650 | Batch BT-2953Mfg Oct 2024 · Exp Sep 2027 | Biosearch Organics D.I.C Ind.Estate | Thesample does not conform to I.P w.r.t the test for," Dissolution"Dissolution | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Ranitidine Oral Solution IP | Batch SR-017Mfg Jun 2024 · Exp May 2026 | Sresan Pharmaceutical ManufacturerKarnataka | This particular batch of sample fails the test Assay of Ranitidine.Assay | RDTL ErnakulamState lab |
| Ranitidine Oral Solution IP | Batch AL24011221DMfg Jan 2024 · Exp Dec 2025 | Accura Care Pharmaceuticals Pvt. LtdHimachal Pradesh | Content of RanitidineOther | SDT&RL, BhubaneswarState lab |
| Ranitidine Hydrochloride Tablets IP 150mg | Batch AZCT-2505Mfg May 2025 · Exp Apr 2027 | Seldom Pharma Pvt. LtdPuducherry | Circular orange colored, biconvex plain on both sides. Two types of colored tablets observed while opening from the strips. Some tablets are light brown colored and some tablets are orange colored, hence Description (Appearance) test parameter does not complies as per IP specification.Description | DCL TelanganaState lab |
| Ramipril Tablets IP 5 mg | Batch TGT25-165Mfg Jul 2025 · Exp Jun 2027 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab |
| Ramipril Tablets IP 2.5 mg | Batch PT-44206Mfg Dec 2024 · Exp Nov 2026 | Pharmaroots HealthcareHimachal Pradesh | Test for Dissolution & Assay for RAmiprilAssay | RDTL, Hubli, KarnatakaState lab |
| Ramipril Tablets IP | Batch SD-1457Mfg Jul 2025 · Exp Jun 2027 | Sano-Cito Therapeutics IncHimachal Pradesh | The sample does not conform to the IP with respect to Assay and DissolutionAssay | DTL, JaipurState lab |
| Ramipril Tablets IP | Batch GVD0644Mfg Jan 2025 · Exp Dec 2025 | Ved Lifesavers (P) LtdUttarakhand | The sample does not conform to the claim with respect to Assay & DissolutionAssay | DTL, JaipurState lab |
| Ramipril & Metoprolol Succinate Sustain Release Tablets | Batch T24K554AMfg Nov 2024 · Exp Oct 2026 | Bajaj FormulationUttarakhand | The sample does not conform to the claim with respect to Assay of RamipriAssay | DTL, JaipurState lab |
| Rabeprazole Sodium Injection IP 20mg/vial | Batch MD25B18Mfg Feb 2025 · Exp Jan 2027 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to I.P with respect to test for "Clarity of solution", "Particulate matter", "Sterility" and "Description".Description | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium (Enteric Coated) & Domperidone (SR) Capsules | Batch ICK0222Mfg Sep 2024 · Exp Aug 2026 | Innova Captab LtdHimachal Pradesh | The sample does not conform to Manufacturer Specification with respect to the Assay of Rabeprazole Sodium.Assay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium (EC)n & Dompoeridone SR Capsule | Batch C011H03Mfg Jun 2024 · Exp May 2026 | Bioconic RemediesHimachal Pradesh | Rabeprazole content-75.01 %Other | Food & Drugs Laboratory, VadodaraState lab |
| Rabeprazole Sodium Tablets IP 20mg, | Batch T25.018Mfg Jun 2025 · Exp Dec 2026 | Oaksun LifesciencesTelangana | It fails the test "Dissolution". as per IP, as specified in the Laboratory Protocol.Dissolution | DTL KonniState lab |
| Rabeprazole & Domperidone Capsules | Batch ORECA-004Mfg Apr 2024 · Exp Mar 2026 | Laborate Pharmaceuticals India Ltd (Unit-ii) 31Himachal Pradesh | Rabeprazole & Domperidone Capsules does not comply Rabeprazole sodium Assay as per STPAssay | DCL TelanganaState lab |
| Prednisolone Acetate Opthalmic Suspension USP | Batch 2.4000000000000001E+29Mfg May 2024 · Exp Apr 2026 | Contacare Ophthalmics and DiagnosticsGujarat | Assay for Predniosolone acetateAssay | DTL, Bengaluru, KarnatakaState lab |
| Povidone-Iodine Solution IP 10%w/v | Batch 121Mfg Jul 2024 · Exp Jun 2026 | Algen Healthcare Ltd 134/2Himachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for pH of Povidone-Iodine Solution.pH | RDTL, GuwahatiCDSCO lab |
| Povidone - Iodine & Metronidazole Ointment | Batch 5C10Mfg Mar 2025 · Exp Feb 2027 | Zenith Drugs Pvt. LtdMadhya Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Potassium Chloride Liquid 200 ml | Batch 957Mfg Apr 2025 · Exp Mar 2027 | Sunny Industries Private Ltd. 23/3/1BWest Bengal | The sample does not conform to Manufacturers Specification with respect to the test of pH.pH | CDL, KolkataCDSCO lab |
| Polygeline Intravenous Infusion (3.5% w/v Polygeline colloidal solution with electrolytes) | Batch 24EPT019Mfg Nov 2024 · Exp Oct 2026 | Pentagon Labs Ltd. 16C/16D | The sample does not conform to claim as per Patent and Proprietary (RDTL/MS/4136) in respect to the Test of Particulate matter, Assay of Potassium and Total Chloride.Assay | RDTL,ChandigarhCDSCO lab |
| Pheniramine Maleate Injection I.P. | Batch 2123054Mfg Jun 2023 · Exp May 2026 | Sanofi India LtdGujarat | The sample does not conform to IP with respect to test for Sterility.Sterility | CDL, KolkataCDSCO lab |
| Paracetamol, Phenylephrine HCl & Chlorpheniramine Maleate Suspension | Batch IHP0047Mfg Aug 2025 · Exp Jul 2027 | Infiniheal PharmaceuticalsGujarat | Total Aerobic Microbial CountMicrobial limits | Food & Drugs Laboratory, VadodaraState lab |
| Paracetamol and Tramadol Hydrochloride Tablets IP | Batch LBHK25001Mfg Feb 2025 · Exp Jan 2028 | Chimak Health CareHimachal Pradesh | The sample does not conform to IP Standards with respect to Dissolution.Dissolution | DTL ThrissurState lab |
| Paracetamol Tablets IP 650mg | Batch TEM24011ALMfg Oct 2024 · Exp Sep 2026 | Hindustan Laboratories LimitedMaharashtra | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Paracetamol Tablets IP 650 mg) | Batch DT2502044CMfg Feb 2025 · Exp Jan 2027 | Indorama Health Care Pvt LtdHaryana | Test for Dissolution" and "DescriptionDissolution | DTL, Bengaluru, KarnatakaState lab |
| Paracetamol Tablets IP 650 mg | Batch PCT25093Mfg May 2025 · Exp Apr 2027 | Vivek Pharmachem (India) LtdRajasthan | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab |
| Paracetamol Tablets IP 500 | Batch GPL23033Mfg Aug 2023 · Exp Jul 2026 | IBN Herbals (A unit of curetech formulation (P) Ltd) Khasara No. 63Himachal Pradesh | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab |
| Paracetamol Tablets IP - 650 mg | Batch 1515Mfg Mar 2025 · Exp Feb 2028 | Alpha Pharmaceuticals 41Haryana | The sample does not conform to I.P With respect to test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Paracetamol Tablets IP | Batch SPT-9584AMfg Nov 2024 · Exp Oct 2026 | Shivani PharmaceuticalsHimachal Pradesh | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab |
| Paracetamol Paediatric Syrup IP | Batch SP-684Mfg Nov 2024 · Exp Nov 2026 | South East pharmaceuticalsTamil Nadu | Impurity (EG) Limit:Not More than 0.1%, Present-0.385%Other | Drugs Testing Laboratory, Chennai-06State lab |
| Paracetamol Paediatric Syrup IP | Batch SP-683Mfg Nov 2024 · Exp Nov 2026 | South East pharmaceuticalsTamil Nadu | Impurity (EG) Limit:Not More than 0.1%, Present-0.4%Other | Drugs Testing Laboratory, Chennai-06State lab |
| Pantoprazole Tablets IP 40mg. | Batch N2501055Mfg Mar 2025 · Exp Feb 2028 | Intas Pharmaceuticals LtdSikkim | The sample does not conform to I.P with respect to the test for "Dissolution in Buffer Stage:.Dissolution | CDTL,IndoreCDSCO lab |
| Pantoprazole Tablets IP 40 mg | Batch 25A-T126BMfg Apr 2025 · Exp Mar 2027 | Orison Pharma InternationalHimachal Pradesh | The sample does not conform to I.P 2022 requirements w.r.t the test for," Dissolution"Dissolution | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Pantoprazole Sodium Gastro-resistant and Domperidone Prolonged -release Capsules IP | Batch SPA250021Mfg Jan 2025 · Exp Dec 2026 | Aristo Pharmaceuticals Pvt. LtdSikkim | The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC and Assay of Pantoprazole Sodium calculated as Pantoprazole, Domperidone.Assay | RDTL,ChandigarhCDSCO lab |
| Pantoprazole Gastro-resistant Tablets IP 40 mg | Batch CHPLT672Mfg Jan 2025 · Exp Dec 2026 | Cureza Healthcare Pvt. Ltd. 63/1Madhya Pradesh | The sample does not conform to IP with respect to test for "Dissolution" and "Description".Dissolution | CDL, KolkataCDSCO lab |
| Omeprazole Capsule IP 20 mg | Batch 153/25Mfg Jan 2025 · Exp Dec 2026 | Aban PharmaceuticalsKerala | Dissolution (Buffer satage)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Ofloxacin and Ornidazole Tablets IP | Batch VT250644Mfg Jun 2025 · Exp May 2027 | VADSP PharmaceuticalsHimachal Pradesh | The sample does ot conforms to claim as per IP 2022 in respect to the Test of Dissolution of Ofloxacin & Ornidazole.Dissolution | DTL, BADDI H.PState lab |
| Ofloxacin Tab IP 200mg | Batch YLT25025Mfg Jun 2025 · Exp May 2027 | YL PharmaHimachal Pradesh | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Nitrazepam Tablets IP 10mg | Batch AXZ24003PMfg Jan 2024 · Exp Jun 2028 | Anglo-French Drugs & Industries LtdKarnataka | The sample does not give IP identification for the presence of Nitrazepam, The sample is decalred as spuriousIdentification | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab |
| Nifedipine Sustained Release Tablets IP 20 mg | Batch 3442505Mfg Jul 2025 · Exp Jun 2027 | Towa Pharma Private Limited | Dissolution Stage 1Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Nifedipine Sustained Release Tablets IP 10 mg | Batch T250809Mfg Aug 2025 · Exp Jul 2027 | Medisky Pharmaceuticals Pvt. Ltd | Dissolution Stage 1Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Naltrexone HCL Tablets IP 50 mg | Batch T2507109Mfg Jul 2025 · Exp Jun 2027 | Micron Pharmaceuticals | Brittle TabletsOther | Food & Drugs Laboratory, VadodaraState lab |
| Naltrexone HCL Tablets IP 50 mg | Batch T250651Mfg Jun 2025 · Exp May 2027 | Micron Pharmaceuticals | Brittle TabletsOther | Food & Drugs Laboratory, VadodaraState lab |
| Montelukast & Levocetirizine Tablets IP | Batch LCM-5061Mfg Jun 2025 · Exp May 2027 | Spinka PharmaTelangana | This particular batch of sample fails the test Dissolution of Montelukast.Dissolution | RDTL ErnakulamState lab |
| Milk of Magnesia, Liquid Paraffin & Sodium Picosulphate Suspension | Batch LXFPL606Mfg Dec 2024 · Exp Nov 2026 | Tulbros Formulations | Description onlyDescription | RDTL, Hubli, KarnatakaState lab |
| Metronidazole Tablets IP 400mg | Batch RMTT-049Mfg Sep 2025 · Exp Aug 2027 | Revat Laboratories Pvt. Ltd. 12-321 | The sample received does not conform to IP 2022, IP Addendum 2024 specification with respect to the description only.Description | CDTL,HyderabadCDSCO lab |
| Metronidazole Tablets IP 200 mg | Batch MZ241004Mfg Oct 2024 · Exp Sep 2026 | Cipcoo Pharmaceuticals 35-36/1Madhya Pradesh | Sample does not comply Dissolution parameter as per Metronidazole Tablets IP of IP 2022.Dissolution | DCL TelanganaState lab |
| Metoprolol Injection IP | Batch DAB004Mfg Apr 2025 · Exp Mar 2027 | Dial PharmaceuticalsGujarat | Bacterial Endotoxins & SterilitySterility | Food & Drugs Laboratory, VadodaraState lab |
| Methylprednisolone Tablets IP 4mg | Batch TGT25-091Mfg Apr 2025 · Exp Mar 2027 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab |
| Metformin Hydrochloride Tablets IP 1000 mg | Batch DL-60Mfg Oct 2024 · Exp Sep 2026 | Dutch Formulations 32Himachal Pradesh | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test Uniformity of weight and Assay of Metformin Hydrochloride.Assay | RDTL,ChandigarhCDSCO lab |
| Metformin Hydrochloride Prolonged Release and Glimepiride Tablets I.P. | Batch VPP11224Mfg Dec 2024 · Exp Nov 2026 | Suraksha Pharma Pvt. LtdUttarakhand | The sample received does not conform to I.P. 2022 specification with respect to the description only.Description | CDTL,HyderabadCDSCO lab |
| Metformin Hydrochloride Prolonged Release and Glimepiride Tablets I.P (500mg/2mg) | Batch PRT-250235Mfg Feb 2025 · Exp Jan 2027 | Preet Remedies LtdHimachal Pradesh | Dissolution test for GlimepirideDissolution | RDTL, Bellary, KarnatakaState lab |
| Meropenam Injection IP 500 mg | Batch PMI3519Mfg Jun 2025 · Exp May 2027 | Modern LaboratoriesMadhya Pradesh | bacterial EndotoxinsBacterial endotoxins | Food & Drugs Laboratory, VadodaraState lab |
| Mecobalamin Tablets 1500 mcg | Batch ILM-56002Mfg Jul 2025 · Exp Jun 2027 | Sain Medicaments Pvt. Ltd. P-2/4Telangana | The sample does not comply with the test for Disintegration for oral dissolving tablets. Out of 18 tablets, only two tablets disintegrated within 3 minutes in water. Hence the sample does not comply with the test for disintegration.Disintegration | DCL TelanganaState lab |
| Mebeverine Hydrochloride and Chlordiazepoxide Tablets | Batch NTE0566AMfg Sep 2024 · Exp Aug 2026 | Digital Vision 176Himachal Pradesh | The sample does not conform to claim with respect to the tests of Disintegration, Assay of Mebeverine Hydrochloride and Assay of Chlordiazepoxide.Assay | CDL, KolkataCDSCO lab |
| Lexof-O+ (Ofloxacin, Ornidazole & Saccharomyces Boulardii Tablets) | Batch T25C442AMfg Mar 2025 · Exp Feb 2027 | Bajaj FormulationUttarakhand | Test for Uniformity of Weight onlyUniformity of weight/content | RDTL, Hubli, KarnatakaState lab |
| Levosalbutamol, Ambroxol HCL & Guaiphenesin Syrup | Batch XL983Mfg Sep 2024 · Exp Aug 2026 | Saphnix Life SciencesHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol Sulphate, Ambroxol HCl & Guaiphensin Syrup | Batch SP25195Mfg Mar 2025 · Exp Feb 2027 | Seejar Pharmaceuticals | Assay for Guaiphenesin and Ambroxol HydrochlorideAssay | DTL, Bengaluru, KarnatakaState lab |
| Levosalbutamol Sulphate Syrup 1mg/5ml | Batch L24/0639AMfg Mar 2025 · Exp Feb 2027 | Samkem 15-B & 10-BMadhya Pradesh | The sample received does not conform to manufactures specification with respect to the test for assay only.Assay | CDTL,HyderabadCDSCO lab |
| Levocetirizine Dihydrochloride & Montelukast Sodium Tablets | Batch YLT25029Mfg Sep 2025 · Exp Aug 2027 | YL PharmaHimachal Pradesh | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Levocetirizine DiHydrochloride Tablets | Batch YLT25028Mfg Jul 2025 · Exp Jun 2027 | YL PharmaHimachal Pradesh | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Lactulose Solution USP | Batch JL-240147Mfg Oct 2024 · Exp Sep 2026 | Jineka Healthcare Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Ketorolac Tromethamine Tablets IP 10mg | Batch TGT25-096Mfg Apr 2025 · Exp Mar 2027 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab |
| Itraconazole Capsule IP 100mg | Batch 1725-230Mfg Apr 2025 · Exp Sep 2027 | Zee Laboratories Ltd. Behind 47Himachal Pradesh | The sample does not conforrm to the IP with respect to DissolutionDissolution | DTL, JaipurState lab |
| Iron Sucrose Injection USP 100mg/5ml | Batch 24RS14Mfg Dec 2024 · Exp Nov 2026 | SAI Parenterals LimitedTelangana | The sample does not conform to U.S.P with respect to test for pH and AlkalinitypH | CDL, KolkataCDSCO lab |
| Ibuprofen Tablets I.P. 400 mg | Batch INT 3504Mfg Aug 2025 · Exp Jul 2027 | Modern LaboratoriesMadhya Pradesh | The sample does not conform to standard quality in respect of the tests for "Description" performed.Description | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| Ibuprofen Tablets I.P. 400 mg | Batch INT 3505Mfg Aug 2025 · Exp Jul 2027 | Modern LaboratoriesMadhya Pradesh | The sample does not conform to standard quality in respect of the tests for "Description" performed.Description | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| IRON AND FOLIC ACID TABLETS IP (Iron 60mg and Folic acid 0.5mg) | Batch IQTB-39Mfg Jan 2024 · Exp Dec 2025 | Nestor Pharmaceuticals LimitedHaryana | Uniformity of Content & Assay for Folic AcidAssay | SDT&RL, BhubaneswarState lab |
| INFUSION SET-NV | Batch KT-046Mfg Apr 2024 · Exp Mar 2027 | Medivision Healthcare 84/4 Span Industrial complex.Second FloorGujarat | The sample does not comply as per IP 2022 & IS 12655 (Part 4): 2003 with respect to the tests for "Sterility and Packaging" of the Infusion sets.Sterility | RDTL, GuwahatiCDSCO lab |
| IBUT Plus | Batch T5863Mfg Feb 2024 · Exp Jan 2027 | Leben Laboratories Pvt.Ltd.Office;11Maharashtra | The sample does not conform to I.P 2022 requirements w.r.t the test for," Dissolution"Dissolution | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Hydroxyzine HCL Oral Solution IP 10 mg | Batch R09GL2545AMfg Sep 2025 · Exp Aug 2027 | Rednex PharmaceuticalsGujarat | The sample received does not conform to I.P. 2022 with respect to the test for pH..pH | CDTL, MumbaiCDSCO lab |
| Hydrogen Peroxide Topical Solution USP 3% w/v 10 Vol | Batch HP/19/25Mfg Apr 2025 · Exp Sep 2026 | Prem Laboratories D.No. 16-9-749/36/BTelangana | Sample does not comply assay and acidity parameters as per USP.Assay | DCL TelanganaState lab |
| Glimepiride, Pioglitazone Hydrochloride and Metformin Hydrochloride Sustained-release Tablets (2mg/15mg/500mg) | Batch GMPT-1050Mfg Jan 2024 · Exp Dec 2025 | Wings Biotech LLPHimachal Pradesh | Assay for Glimepiride" onlyAssay | RDTL, Hubli, KarnatakaState lab |
| Glimepiride, Metformin Hydrochloride (SR) and Voglibose Tablets | Batch SSGT-2401Mfg Oct 2024 · Exp Sep 2026 | Verax Life Sciences Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Glimepiride Tablets IP.2mg | Batch GP08Mfg Sep 2024 · Exp Aug 2027 | Mahendra Labs Pvt. LtdKarnataka | Test for DissolutionDissolution | RDTL, Hubli, KarnatakaState lab |
| Glimepiride Tablets IP 2mg | Batch GL 4142Mfg Nov 2024 · Exp Oct 2026 | Kerala State Drugs and Pharmaceuticals LtdKerala | It fails the test "Dissolution". as per IP.Dissolution | DTL ThrissurState lab |
| Glimepiride Tablets IP 2mg | Batch TGT25-090Mfg Apr 2025 · Exp Mar 2027 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab |
| Glimepiride Tablets IP 1 mg | Batch TA24826Mfg Oct 2024 · Exp Sep 2026 | Saintlife Pharmaceuticals LtdUttarakhand | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab |
| Gentamicin Sulphate Injection I.P | Batch MA25C13Mfg Mar 2025 · Exp Feb 2027 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | Assay for GentamicinAssay | DTL, Bengaluru, KarnatakaState lab |
| Gastro-Resistant Omeprazole Capsules BP 10 mg | Batch C-3023Mfg Oct 2024 · Exp Apr 2026 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample does not conform to claim as per B.P. in respect to the Test of Dissolution (Final Stage, PH 6.8)Dissolution | CDL, KolkataCDSCO lab |
| GLYCERIN I.P | Batch RPE011Mfg Jul 2025 · Exp Jun 2028 | The Swastik PharmaceuticalsAndhra Pradesh | The sample does not conform to standard quality in respect of the test for "Assay" performed.Assay | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE PROLONGED RELEASE TABLETS IP(2mg + 500 mg) | Batch G522501BMfg Feb 2025 · Exp Jan 2027 | Lifecare Formulations Pvt. LtdPuducherry | Assay (for GLIMEPIRIDE)Assay | DTL, PuducherryState lab |
| Folic Acid Tablets IP 5 mg | Batch CH24223Mfg Nov 2024 · Exp Oct 2026 | Chalice Vitalchem Pvt. LtdHimachal Pradesh | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test of Dissolution.Dissolution | RDTL,ChandigarhCDSCO lab |
| Folic Acid Tablets IP | Batch FTV25002Mfg Mar 2025 · Exp Feb 2027 | Danish Health Care (P) Ltd | Description & DissolutionDissolution | Food & Drugs Laboratory, VadodaraState lab |
| Fluorometholone Ophthalmic Solution USP | Batch E240423AMfg Apr 2024 · Exp Mar 2026 | Oscar Remedies Pvt. Ltd | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab |
| Ferrous Ascorbate, Folic Acid & Zinc Tablets | Batch MMT-11855Mfg Dec 2024 · Exp May 2026 | Mayford Pharma Near Railway crossingHimachal Pradesh | Assay of Elemental Iron does not comply as per STP and as per IP 2022 the label should state the strength in terms of Ferrous ascorbate equivalent to Elemental Iron, but Ferin-XT tablets label is not mentioned Ferrous Ascorbate equivalent to Elemental Iron. Hence sample deemed to be Misbranded as per Section 17 of D & C act 1940.Assay | DCL TelanganaState lab |
| Ferric Carboxymaltose Injection 50 mg/ml | Batch BI240239AMfg Dec 2024 · Exp Nov 2026 | BDR Pharmaceuticals Intl Pvt. Ltd. Vanseti | The sample does not conform to Manufacturer Specification with respect to the Test of Particulate matterParticulate matter | CDL, KolkataCDSCO lab |
| Enteric Coated Rabeprazole Sodium&Domperidone Sustained Release Capsules | Batch C-24186Mfg Aug 2024 · Exp Jul 2026 | Sunlife Sciences 130Uttarakhand | Enteric Coated Rabeprazole & Domperidone sustained Release Capsules does not comply Assay of Rabeprazole sodium as per STP.Assay | DCL TelanganaState lab |
| EMIZ PLUS | Batch GT-25017Mfg Mar 2025 · Exp Feb 2027 | Green Enviro CoHimachal Pradesh | Orally disintegrating tablets (ODT)Other | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Dried Aluminium Hydroxide Gel, Magnesium Hydroxide and Simethicone Suspension IP | Batch ECL/25/146Mfg Jun 2025 · Exp May 2027 | Emmchak Formulations Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Dried Aluminium Hydroxide Gel I.P. 250 mg | Batch 25001Mfg May 2025 · Exp Apr 2027 | Diamond Drugs Pvt. Ltd 94West Bengal | The sample does not conform to claim as per Manufacturers Spec in respect of the test Assay for Sorbitol.Assay | CDL, KolkataCDSCO lab |
| Doxycycline Hydrochloride Capsule IP 100 mg | Batch C5009Mfg Jul 2025 · Exp Jun 2027 | Zest PharmaMadhya Pradesh | Dissolution (Doxycycline)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Doxycycline Hydrochloride Capsule IP 100 mg | Batch C5007Mfg Jul 2025 · Exp Jun 2027 | Zest PharmaMadhya Pradesh | Dissolution (Doxycycline)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Doxycycline Capsules IP100mg | Batch C50174Mfg May 2025 · Exp Apr 2027 | Zenith Drugs Pvt. LtdMadhya Pradesh | UniformityUniformity of weight/content | Drugs Testing Laboratory, Madurai-19State lab |
| Dicyclomine Tablets IP 10mg | Batch DC24002Mfg Nov 2024 · Exp Oct 2026 | EUROKEM Laboratories Pvt.Ltd. C-25Tamil Nadu | Tablets are not intact condition. when strip is opended, tablets found to be in powdered state. Hence Dicyclomine tablets does not meet the Specifications Wrt. DescriptionDescription | DCL TelanganaState lab |
| Diclofenac Sodium Tablets IP 50 mg | Batch B250895Mfg Jun 2025 · Exp May 2027 | Bochem Healthcare Pvt. Ltd | Dissolution (Buffer stage)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Dextromethorphan Hydrobromide, Paracetamol & Phenylephrine HCl Suspension | Batch IHP0022Mfg May 2025 · Exp Apr 2027 | Infiniheal PharmaceuticalsGujarat | Total Aerobic Microbial CountMicrobial limits | Food & Drugs Laboratory, VadodaraState lab |
| Dextromethorphan Hydrobromide Syrup IP. | Batch 1B0453Mfg Jul 2026 · Exp Jun 2027 | Deep PharmaGujarat | The sample received does not conform to I.P. 2022 with respect to the test for Microbial limit testMicrobial limits | CDTL, MumbaiCDSCO lab |
| Dexamethasone Tablets IP 0.5mg | Batch TA24660Mfg Aug 2024 · Exp Jul 2026 | Saintlife Pharmaceuticals LtdUttarakhand | DefinitionOther | Drugs Testing Laboratory, Chennai-06State lab |
| Deflazacort Tablets | Batch TGT25-092Mfg Apr 2025 · Exp Mar 2027 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab |
| DICLOFENAC DIETHYLAMINE, MENTHOL & METHYLSALICYLATE LINIMENT | Batch 677Mfg Mar 2025 · Exp Aug 2026 | M/S Argion Cosmed India Pvt LtdTamil Nadu | Assay (for Methylsalicylate)Assay | DTL, PuducherryState lab |
| DIAZEPAM INJECTION IP -2ml | Batch DA-2411Mfg Apr 2024 · Exp Mar 2026 | Systochem Laboratories Ltd. B-75 Roop Nagar | The sample does not conform to I.P. with respect to the tests of Identification of Diazepam, pH, Particulate Matter, Sterility, Assay of Diazepam and Description.Assay | CDL, KolkataCDSCO lab |
| DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE SYRUP | Batch 3261Mfg Sep 2024 · Exp Aug 2026 | Apshsri PharmaceuticalsTamil Nadu | Assay (for Phenylephrine Hydrochloride and Chlorpheniramine Maleate)Assay | DTL, PuducherryState lab |
| DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE & CHLORPHENIRAMINE MALEATE SYRUP | Batch AA24004AMfg Nov 2024 · Exp Oct 2026 | Bengene Life Sciences Pvt. Ltd. R.S.No.: 239/2 | Incorrect labellingLabelling | DTL, PuducherryState lab |
| DEXTROMETHORPHAN HYDROBROMIDE 10mg, CHLORPHENIRAMINE MALEATE 2mg WITH PHENYLEPHRINE HYDROCHLORIDE 5 mg SYRUP | Batch TZ0L-022Mfg May 2025 · Exp Apr 2027 | Tanmed Pharma (I) Pvt LtdTamil Nadu | Assay (for Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride)Assay | DTL, PuducherryState lab |
| Cyproheptadine Hydrochloride Syrup IP | Batch SR-086Mfg Dec 2024 · Exp Nov 2026 | Sresan Pharmaceutical ManufacturerKarnataka | The smple fails in the test PH and AssayAssay | RDTL ErnakulamState lab |
| Cyproheptadine Hydrochloride Syrup | Batch SR-46Mfg Aug 2025 · Exp Jul 2027 | Sresan Pharmaceutical ManufacturerKarnataka | pHpH | Drugs Testing Laboratory, Chennai-06State lab |
| Cyclopam | Batch 24070676Mfg Dec 2024 · Exp May 2026 | Indoco Remedies Ltd B-20Maharashtra | "The sample does not conform to I.P 2022 requirements with respect to the test for uniformity of weight."Uniformity of weight/content | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Cufcott LS Cough Syrup | Batch CL230203EMfg Dec 2023 · Exp Nov 2025 | Condour PharmaceuticalsHimachal Pradesh | Content of LevosalbutamolOther | SDT&RL, BhubaneswarState lab |
| Compound Sodium Lactate Injection I.P. | Batch 03B3911Mfg Jun 2023 · Exp May 2026 | Paschim Banga Pharmaceuticals NH-31 | The sample does not comply as per I.P. 2022 with respect to the test for "Sterility".Sterility | RDTL, GuwahatiCDSCO lab |
| Colistimithate Sodium for Injection IP | Batch LT25001Mfg Aug 2025 · Exp Jul 2027 | Maan Pharmaceuticals Ltd | Bacterial EndotoxinsBacterial endotoxins | Food & Drugs Laboratory, VadodaraState lab |
| Closantel I.P. 15% W/v & Ivermectin I.P 0.3% W/v Solution | Batch CIG00625Mfg Jul 2025 · Exp Jun 2027 | Stanmax Laboratories Pvt. LtdTelangana | Identification and Assay for IvermectinAssay | DTL, Bengaluru, KarnatakaState lab |
| Clopidogrel and Aspirin Capsules (75mg +75mg | Batch HSP25006Mfg Feb 2025 · Exp Jan 2027 | Hetero Labs LimitedPuducherry | Related substancesRelated substances | Drugs Testing Laboratory, Chennai-06State lab |
| Clopidogrel & Aspirin Tablets IP(75mg/75mg) | Batch GT250375Mfg Feb 2025 · Exp Jan 2027 | Theon Pharmaceuticals LtdHimachal Pradesh | The sample does not conform to IP Standards with respect to Related Substances of Aspirin and Description.Description | DTL ThrissurState lab |
| Clopidogrel & Aspirin Tablets | Batch T250139Mfg Jan 2025 · Exp Dec 2026 | Ikon Pharmachem Pvt. LtdUttarakhand | The sample does not conform to IP Standards with respect to Dissolution, Related Substances and Assay of Aspirin Standards.Assay | DTL ThrissurState lab |
| Clarithromycin Oral Suspension USP | Batch PGD4075AMfg Dec 2024 · Exp Nov 2026 | Plena RemediesHimachal Pradesh | Test for pH and Assay for ClarithromycinAssay | DTL, Bengaluru, KarnatakaState lab |
| Ciprofloxacin Tablets U.S.P. 500 mg.. | Batch T-2408090Mfg Aug 2024 · Exp Jul 2026 | Rivpra Formulation Pvt. LtdUttarakhand | The sample does not conform to claim as per U.S.P. with respect to the test for "Dissolution" of Ciprofloxacin.Dissolution | RDTL, GuwahatiCDSCO lab |
| Ciprofloxacin Hydrochloride Tablets IP 500 mg | Batch JKBD24080Mfg Aug 2024 · Exp Jul 2027 | Cadila Pharmaceuticals Limited | The sample does not conform to IP Standards, It fails the test ' Dissolution' as per IP.Dissolution | DTL ThiruvananthapuramState lab |
| Ciprofloxacin Hydrochloride Tablet IP 500 mg | Batch CDA24002Mfg Oct 2024 · Exp Sep 2026 | Danish Health Care (P) Ltd | Test for DissolutionDissolution | RDTL, Hubli, KarnatakaState lab |
| Ciprofloxacin Hydrochloride & Tinidazole Bolus | Batch CF2523Mfg Mar 2025 · Exp Feb 2027 | Rudraksha BioceuticalsGujarat | Test for Disintegration onlyDisintegration | RDTL, Hubli, KarnatakaState lab |
| Cetirizine Hydrochloride, Phenylephrine Hydrochloride and Dextromethorphan Hydrobromide Syrup | Batch R25053101Mfg Feb 2025 · Exp Jan 2027 | Shreya Lifesciences Pvt. Ltd. 13Uttarakhand | The sample does not conform as per I.P. 2022 with respect to the test for Diethylene Glycol (DEG).Other | RDTL, GuwahatiCDSCO lab |
| Ceftriaxone & Sulbactam Injection | Batch SKY-19Mfg Dec 2024 · Exp Nov 2026 | Argon Remedies Pvt. LtdUttarakhand | Sterility for Sterile Water for InjectionSterility | DTL, Bengaluru, KarnatakaState lab |
| Cefixime and Lactic Acid Bacillus Dispersible Tablets | Batch TB020Mfg Oct 2024 · Exp Sep 2026 | Titanes PharmaHimachal Pradesh | Samples does not comply Assay of Cefixime as per STP.Assay | DCL TelanganaState lab |
| Cefixime Oral suspension IP | Batch DS250075Mfg Jun 2025 · Exp May 2027 | Agron Remedies Pvt. Ltd. Sarverkhera | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Cefixime Dispersible Tablets IP 200mg) | Batch CBEL24012Mfg Mar 2024 · Exp Feb 2026 | Curetech Formulation (P) LtdHimachal Pradesh | Test for Uniformity of WeightUniformity of weight/content | DTL, Bengaluru, KarnatakaState lab |
| Cefixime Dispersible Tablets IP | Batch BT2506033Mfg Jun 2025 · Exp May 2027 | Shri Ramesth IndustriesHimachal Pradesh | Cefixime content 20.54 %Other | Food & Drugs Laboratory, VadodaraState lab |
| Cefipodoxime Proxetil Dispersible Tablets | Batch CT25035GMfg May 2025 · Exp Apr 2027 | Curehealth PharmaceuticalsHimachal Pradesh | The sample does not conform to the IP with respect to ColourDescription | DTL, JaipurState lab |
| Calcium and Vitamin D3 Tablets IP (500mg+250 IU) (Calcium 500mg & Vitamin D3 250 IU) | Batch T572514Mfg Feb 2025 · Exp Jul 2026 | Bengal Chemicals & Pharmaceuticals LtdWest Bengal | This particular batch of sample fails the test 'Dissolution' as per IP.Dissolution | DTL ThrissurState lab |
| Calcium and Vitamin D3 Tablets IP (500mg+250 IU) | Batch T572513Mfg Feb 2025 · Exp Jul 2026 | Bengal Chemicals & Pharmaceuticals LtdHaryana | The sample does not conform to claim as per IP 2022 in respect to the Test of Dissolution of CalciumDissolution | RDTL,ChandigarhCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 5ANL035Mfg Feb 2025 · Exp Jul 2026 | Yacca Life Sciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL076Mfg Aug 2024 · Exp Jan 2026 | Yacca Life Sciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL063Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL080Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL078Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL081Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL064Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL083Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL065Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL082Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL073Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL079Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL041Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL075Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL077Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt LtdUttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | Batch 4ATL042Mfg Aug 2024 · Exp Jan 2026 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Carbonate Tablets IP | Batch 3B1181Mfg Jun 2025 · Exp May 2027 | Deep PharmaGujarat | Dissolution (Calcium)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Calcitriol, Calcium Carbonate, Zinc Oxide, Magnesium Oxide, Vitamin K27, Methylcobalamin & L-Methylfolate Soft Gelatin Capsules | Batch D242039GMfg Aug 2024 · Exp Jul 2026 | Sigma Softgel & FormulationHimachal Pradesh | Test for Disintegration onlyDisintegration | RDTL, Hubli, KarnatakaState lab |
| CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE & PHENYLEPHRINE HYDROCHLORIDE SYRUP | Batch RLRFDC016Mfg Feb 2025 · Exp Jan 2027 | M/s Rosefinch Pharmaceutique Pvt LtdGujarat | Assay (for Chlorpheniramine Maletae)Assay | DTL, PuducherryState lab |
| CHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE HYDROCHLORIDE SYRUP IP | Batch RRM-557Mfg Aug 2025 · Exp Jul 2027 | Redner FormulationsPuducherry | Assay (for Chlorpheniramine Maleate And Phenylephrine Hydrochloride)Assay | DTL, PuducherryState lab |
| Bupivacaine Injection IP | Batch L2022410BMfg Oct 2024 · Exp Sep 2026 | Protech Telelinks Mouza OgliHimachal Pradesh | The sample does not conform to IP with respect to test for 'Particulate Matter' and is also not of standard quality for the reason stated under "Description".Description | CDL, KolkataCDSCO lab |
| Bromhexine Hydrochloride Syrup 4mg/5mL | Batch L25/0111AMfg May 2025 · Exp Apr 2027 | Samkem 15-B & 10-BMadhya Pradesh | The sample received does not conform to manufactures specification with respect to the test for assay only.Assay | CDTL,HyderabadCDSCO lab |
| Beclomethasone Dipropionate & Clotrimazole Cream | Batch 614Mfg Sep 2024 · Exp Aug 2026 | BCL PharamaHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Azithromycin Tablets IP 500 mg. | Batch AYC-2407Mfg Jan 2024 · Exp Dec 2025 | Apple Formulations Pvt. LtdUttarakhand | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Azithromycin.Dissolution | RDTL, GuwahatiCDSCO lab |
| Azithromycin Oral Suspension I.P. | Batch JL-2469Mfg Feb 2025 · Exp Jan 2027 | Jainsons HealthcareUttarakhand | The sample received does not conform to I.P. 2022 with respect to the test for AssayAssay | CDTL, MumbaiCDSCO lab |
| Atropine Sulphate Ophthalmic Solution USP 1% | Batch AP-120Mfg Dec 2024 · Exp Nov 2026 | Sayora Pharma Private LtdHaryana | The sample received does not conform to I.P. 2022 with respect to the test for Relatee substances.Other | CDTL, MumbaiCDSCO lab |
| Atorvastatin and Clopidogrel Capsules | Batch K2501777Mfg Jul 2025 · Exp Jun 2027 | Intas Pharmaceuticals Ltd BagheykholaSikkim | The sample does not conform to claim with respect to Assay of Atorvastatin.Assay | CDL, KolkataCDSCO lab |
| Atorvastatin Tablets IP 10mg | Batch RT-250560Mfg May 2025 · Exp Apr 2027 | Relief Biotech Pvt. LtdDelhi | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Atorvastatin Calcium Tablets IP 40 mg | Batch ART-07Mfg Apr 2024 · Exp Mar 2026 | Agron Remedies Pvt. Ltd. SarverkheraUttarakhand | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | RDTL,ChandigarhCDSCO lab |
| Atorvastatin & Clopidogrel Tablets | Batch MT251814Mfg Jun 2025 · Exp May 2027 | Mascot Health Series Pvt. LtdUttarakhand | The sample received does not conform to Manufacturers specification with respect to the test of Atorvasatin assay.Assay | CDTL, MumbaiCDSCO lab |
| Anti Dandruff Shampoo with Conditioner, | Batch BC190Mfg Jul 2025 · Exp Jun 2028 | Morvin India Health Care Pvt. Ltd. 11Gujarat | The sample does not conform to Manufacturer specification with respect to the test for "Determination of pH value".pH | CDTL, MumbaiCDSCO lab |
| Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tablets | Batch 24KHBT-0194Mfg Oct 2024 · Exp Mar 2026 | Kaalinga Health CareHimachal Pradesh | The content of Clavulanic Acid in the sample is less (i.e. 26.94% of the labelled amount than the Schedule V Limit. Schedule V Limit 90% to 130% of Labelled AmountLabelling | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab |
| Amoxycillin for Injection IP | Batch AMK-18Mfg Dec 2024 · Exp Nov 2026 | Argon Remedies Pvt. LtdUttarakhand | Sterility for Sterile Water for InjectionSterility | DTL, Bengaluru, KarnatakaState lab |
| Amoxycillin & Potassium Clavulanate oral suspension IP | Batch NBD020AMfg Feb 2025 · Exp Jul 2026 | Nexkem Biotech Pvt. LtdHimachal Pradesh | The sample does not comply with the test for Assay of Amoxycillin and Clavulanic Acid and hence it is Not of Standard Quality.Assay | DCL TelanganaState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP (500 mg + 125 mg) | Batch SH240051Mfg Sep 2024 · Exp Aug 2026 | Sotac Healthcare Private LimitedGujarat | The sample does not conform to standard quality in respect of the test for "Assay & Dissolution" performed.Assay | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| Amoxycillin & Potassium Clavulanate & Lactic Acid Bacillus Tablets | Batch MYRTAB-883Mfg Jan 2025 · Exp Jun 2026 | Mayer Lab chambagat Adjesent to Railway crossingHimachal Pradesh | Assay for Clavulanic Acid does not complies as per STP. Uniformity of Weight does not complies as per IP Specifications, since three tablets deviated lower limit ie.95% and three tablets deviated higher limit percentage ie. 105%Assay | DCL TelanganaState lab |
| Amoxycillin & Potassium Clavulanate Tablets I.P | Batch MICTAB-2424Mfg Jun 2025 · Exp Nov 2026 | Micro FormulationsHimachal Pradesh | Test for Dissolution and Assay for Amoxycillin & Potassium ClavulanateAssay | RDTL, Bellary, KarnatakaState lab |
| Amlodipine Tablets IP 5mg | Batch RT-2505104Mfg May 2025 · Exp Apr 2027 | Relief Biotech Pvt. LtdDelhi | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Amitriptyline Tablets IP 25mg | Batch GAMT2Mfg Jun 2025 · Exp May 2027 | Super Formulations Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Amitriptyline Tablets IP 25 mg | Batch AMT1305Mfg May 2025 · Exp Apr 2027 | Unicure India LtdUttar Pradesh | UniformityUniformity of weight/content | Drugs Testing Laboratory, Madurai-19State lab |
| Amitriptyline Tablets IP 25 mg | Batch GAMT1Mfg May 2025 · Exp Apr 2027 | Super Formulations Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Amitriptyline Tablets IP | Batch DRT25096Mfg Apr 2025 · Exp Mar 2027 | Eastern HealthcareUttarakhand | The sample does not conform to claim as per IP 2022 in respect to the Test of DescriptionDescription | RDTL,ChandigarhCDSCO lab |
| Ambroxol, Levosalbutamol and Guaiphenesin Syrup, | Batch BM24022Mfg Jun 2025 · Exp May 2027 | Bio Neutraceuticals D.no.8-290/1 | The sample received does not conform to manufacturer's specification with respect to the test for Ph only.pH | CDTL,HyderabadCDSCO lab |
| Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate and Menthol Syrup | Batch 24338Mfg Nov 2024 · Exp Oct 2026 | Zeta Formulation Private Limited | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Ambroxol HCl, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup) | Batch XL1625Mfg Nov 2024 · Exp Oct 2026 | Saphnix Life SciencesHimachal Pradesh | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Ambroxol HCL, Levosalbutamol and Guaiphenesin Syrup | Batch IQ-337CMfg Mar 2025 · Exp Feb 2027 | Go-ish Remedies Limited (Unit-II)Himachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Aluminium, Magnesium and Simethicone Oral Suspension IP | Batch L25/0172AMfg Jun 2025 · Exp May 2027 | SamkemMadhya Pradesh | General DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab |
| Aluminium Hydroxide, Magnesium Hydroxide and Simethicone Oral Suspension IP | Batch ECL/25/026Mfg Apr 2025 · Exp Mar 2027 | Emmchak Formulations Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Alprazolam Tablets IP (0.5 mg) | Batch 3332Mfg May 2024 · Exp Apr 2027 | Reliance Formulation Pvt. Ltd. 7/2-AGujarat | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | RDTL,ChandigarhCDSCO lab |
| Adrenochrome Monosemicarbazone 1mg | Batch CA025005Mfg Jun 2025 · Exp May 2028 | Life Pharmaceuticals Pvt. Ltd. 53(P) And 54(P) Uluberia Industrial Growth Centre Howrah-711316West Bengal | The sample does not conform to claim with respect to test for 'Particulate matter', and 'Description'.Description | CDL, KolkataCDSCO lab |
| Aceclofenac & Paracetamol Tablets | Batch GT16375AMfg Nov 2024 · Exp Oct 2026 | J.M. LaboratoriesHimachal Pradesh | It fails the test Dissolution and Assay as per IP.Assay | RDTL ErnakulamState lab |
| ASPIRIN TABLETS I.P. 75 MG | Batch 241271Mfg Dec 2024 · Exp Nov 2027 | Modi AntibioticsGujarat | 1) The Sample does not Comply for Description as White Circular Powdery Tablets which are too brittle in nature shows needle shaped Crystals in all the blister Packets.2) The Content of Aspirin in the Sample is less (i.e. 69.84% of Stated amount) than the IP Limits. (IP Limit - Not less than 95% and Not more than 105% of stated Amount)Description | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab |
| ASPIRIN TABLETS I.P. 75 MG | Batch 240604Mfg Jun 2024 · Exp May 2027 | Modi AntibioticsGujarat | 1) The Sample does not Comply for Description as White Circular Powdery Tablets which are too brittle in nature shows needle shaped Crystals in all the blister Packets. 2)The Sample does not give IP Identification for the Presence of Aspirin. 3) The Sample gives additional Identification for the Presence of Salicylic Acid. 4) Found Content of Salicylic Acid in the Sample is 73.68 mg/Tablet.Description | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab |
| AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN AND MENTHOL SYRUP | Batch CL-24083Mfg Dec 2024 · Exp Nov 2026 | Casid Pharmaceuticals Private LimitedTamil Nadu | Incorrect labellingLabelling | DTL, PuducherryState lab |
| ALBENDAZOLE TABLETS I.P. 400 mg | Batch FGT7J502Mfg Sep 2025 · Exp Aug 2028 | Zim Laboratories LimitedMaharashtra | The sample does not conform to standard quality in respect of the test for "Dissolution" performed.Dissolution | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| ALBENDAZOLE TABLETS I.P. 400 mg | Batch FGT7J501Mfg Sep 2025 · Exp Aug 2028 | Zim Laboratories LimitedMaharashtra | The sample does not conform to standard quality in respect of the test for "Dissolution" performed.Dissolution | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| (Povidone Iodine Ointment USP 5% W/W) | Batch ADE25105Mfg Jan 2025 · Exp Dec 2026 | Astonea Labs Pvt. LtdHaryana | Assay for Available IodineAssay | DTL, Bengaluru, KarnatakaState lab |
| (Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin Syrup) | Batch VS2523Mfg Jul 2025 · Exp Jun 2027 | Vertex Pharma ChemicalsPuducherry | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| (Clobetasol Propionate & Salicylic Acid Ointment) | Batch 5550Mfg Jul 2025 · Exp Jun 2027 | Canixa Life Sciences Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| (Ambroxol Hydrochloride, Salbutamol, Guaifenesin and Menthol) | Batch XL002Mfg Feb 2023 · Exp Jan 2026 | Intermed Laboratories Private LimitedTamil Nadu | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
Suspected spurious batches in this alert
| Product | Batch | Labelled manufacturer | Reported by | Firm's reply |
|---|---|---|---|---|
| Pantoprazole Gastro-resistant Tablets IP (PAN 40) | 24440478 | Under Investigation | RDTL,Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Telmisartan Tablets I.P. 40 mg (Telma 40) | 18240413 | Under Investigation | RDTL,Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (216 rows). Revised CDSCO lists are diffed on each monthly rebuild.